Back to results
US 6,566,560 B2Granted
Resorcinolic compounds
AssigneeImmugen Pharmaceuticals, Inc.
InventorCraig R. Travis
Life of this patent
Estimating the term…
Abstract
The invention provides a resorcinol derivative and a method of using the resorcinol derivative to attenuate the growth of a neoplasm.
Claims19
A resorcinol derivative that has the following formula:
- wherein, R1, R3, R5, and R6 can optionally comprise —CO at the first position, and wherein R can otherwise be as follows
- R1 is:
- a lactone, OCH3, —CH(CH3)CO2H, or —OCOCH3;
- R2 is:
- a halogen or COOH;
- R3 is:
- a C5-12 alkyl;
- haloalkyl, alkenyl, haloalkenyl, alkynyl, or haloalkynyl, group, or mixture thereof;
- R4 is:
- bromine
- R5 is:
- a lactone, H, OH, or OCH3;
- and
- R6 is:
- ethyl, —CH(CH3)CO2H, CH2COOH, or —OCOCH3.
12 more elements
Dependencies are inferred from the claim text.